Biotricity is trading 14.18% lower at $0.05, with the reason for the decline unclear.
- No clear company-specific announcement or filing dated October 26, 2026, appeared in company news or financial-report listings; the latest listed company news predates the session.
- Broad-market context is positive, but Biotricity is moving in the opposite direction, and available evidence does not establish a market-wide explanation or specific cause.